Banque Pictet & Cie Sa Regeneron Pharmaceuticals, Inc. Transaction History

Banque Pictet & Cie Sa

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 27, 2023	SELL	$692.45 - $844.37 $642,593 - $783,575	-928 Reduced 60.06%	617 $507,000
Q3 2023 Nov 02, 2023	SELL	$692.45 - $844.37 $584,427 - $712,648	-844 Reduced 35.33%	1,545 $1.27 Million
Q2 2023 Aug 04, 2023	SELL	$700.03 - $830.35 $1.05 Million - $1.24 Million	-1,494 Reduced 38.48%	2,389 $1.72 Million
Q1 2023 May 01, 2023	SELL	$680.49 - $826.97 $4.39 Million - $5.34 Million	-6,456 Reduced 62.44%	3,883 $3.19 Million
Q4 2022 Feb 06, 2023	SELL	$705.89 - $766.39 $440,475 - $478,227	-624 Reduced 5.69%	10,339 $0
Q3 2022 Nov 10, 2022	BUY	$573.97 - $724.32 $680,154 - $858,319	1,185 Added 12.12%	10,963 $7.55 Billion
Q2 2022 Aug 08, 2022	BUY	$548.35 - $738.84 $4.85 Million - $6.54 Million	8,850 Added 953.66%	9,778 $5.78 Million
Q4 2019 Feb 03, 2020	BUY	$274.13 - $376.51 $254,392 - $349,401	928 New	928 $348,000
Q4 2018 Jan 31, 2019	SELL	$335.82 - $403.04 $261,939 - $314,371	-780 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$351.14 - $408.51 $204,714 - $238,161	-583 Reduced 42.77%	780 $315,000
Q2 2018 Aug 09, 2018	SELL	$284.6 - $344.99 $1.7 Million - $2.06 Million	-5,964 Reduced 81.4%	1,363 $470,000
Q1 2018 May 09, 2018	SELL	$315.82 - $393.78 $126,328 - $157,512	-400 Reduced 5.18%	7,327 $2.52 Million
Q4 2017 Feb 09, 2018	SELL	$358.63 - $469.95 $472,674 - $619,394	-1,318 Reduced 14.57%	7,727 $2.91 Million
Q3 2017 Nov 07, 2017	BUY	$431.38 - $504.0 $627,657 - $733,320	1,455 Added 19.17%	9,045 $4.05 Million
Q2 2017 Aug 09, 2017	BUY	N/A	7,590	7,590 $3.73 Million

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

Stay updated on Banque Pictet & Cie Sa with notifications on news.